See more : NIKE, Inc. (NKE.BA) Income Statement Analysis – Financial Results
Complete financial analysis of CHC Healthcare Group (4164.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CHC Healthcare Group, a leading company in the Medical – Distribution industry within the Healthcare sector.
- Enzyme Environmental Solutions, Inc. (EESO) Income Statement Analysis – Financial Results
- D & O Green Technologies Berhad (7204.KL) Income Statement Analysis – Financial Results
- BeWhere Holdings Inc. (BEWFF) Income Statement Analysis – Financial Results
- Made SA (MLMAD.PA) Income Statement Analysis – Financial Results
- Kajima Corporation (KAJMY) Income Statement Analysis – Financial Results
CHC Healthcare Group (4164.TW)
About CHC Healthcare Group
CHC Healthcare Group, together with its subsidiaries, provides a range of healthcare management services in Taiwan and internationally. It sells, installs, maintains, leases, and distributes medical equipment. The company is also involved in the provision of business management consultation and education training; elderly care business; and radiation sterilization business. In addition, it offers a range of equipment in the areas of radiation oncology, neurology, medical imaging, ophthalmology, and surgery. The company was founded in 1977 and is headquartered in Taipei, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.88B | 2.97B | 2.44B | 2.55B | 2.95B | 2.51B | 2.12B | 2.21B | 2.40B | 2.09B | 2.06B | 1.99B | 2.00B | 1.87B | 170.40M |
| Cost of Revenue | 2.81B | 2.07B | 1.59B | 1.72B | 2.14B | 1.78B | 1.43B | 1.59B | 1.64B | 1.48B | 1.42B | 1.16B | 1.07B | 989.14M | 129.47M |
| Gross Profit | 1.07B | 902.31M | 849.48M | 830.71M | 806.00M | 730.79M | 688.65M | 619.61M | 759.73M | 606.75M | 638.95M | 833.82M | 923.27M | 878.37M | 40.93M |
| Gross Profit Ratio | 27.55% | 30.34% | 34.82% | 32.51% | 27.32% | 29.14% | 32.53% | 28.10% | 31.72% | 29.02% | 30.97% | 41.91% | 46.27% | 47.03% | 24.02% |
| Research & Development | 0.00 | 0.00 | 0.00 | 6.25M | 4.87M | 1.19M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 235.98M | 238.35M | 233.56M | 191.69M | 166.58M | 192.22M | 222.01M | 174.00M | 253.10M | 137.90M | 131.46M | 163.62M | 94.13M | 69.62M | 8.11M |
| Selling & Marketing | 218.42M | 184.05M | 122.28M | 118.77M | 124.04M | 124.61M | 113.77M | 137.45M | 136.71M | 95.40M | 111.16M | 99.76M | 89.27M | 202.36M | 20.66M |
| SG&A | 454.41M | 422.40M | 355.84M | 310.46M | 290.63M | 316.83M | 335.78M | 311.46M | 389.82M | 233.30M | 242.63M | 263.39M | 183.40M | 271.98M | 28.77M |
| Other Expenses | 0.00 | 67.15M | 42.05M | 17.33M | 27.00M | -5.22M | -299.75M | -9.58M | -20.53M | -8.14M | 716.00K | -28.45M | 1.65M | 3.17M | -687.00K |
| Operating Expenses | 453.64M | 422.40M | 355.84M | 316.71M | 295.50M | 318.02M | 335.78M | 311.46M | 389.82M | 233.30M | 242.63M | 263.39M | 183.40M | 271.98M | 28.77M |
| Cost & Expenses | 3.26B | 2.49B | 1.95B | 2.04B | 2.44B | 2.09B | 1.76B | 1.90B | 2.03B | 1.72B | 1.67B | 1.42B | 1.26B | 1.26B | 158.24M |
| Interest Income | 20.68M | 12.53M | 9.56M | 12.05M | 11.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.59M | 3.50M | 710.00K | 85.00K |
| Interest Expense | 89.00M | 71.27M | 62.52M | 78.21M | 78.34M | 82.07M | 71.51M | 68.32M | 66.52M | 40.90M | 19.55M | 19.28M | 8.58M | 9.74M | 1.02M |
| Depreciation & Amortization | 594.46M | 499.38M | 460.59M | 440.35M | 411.75M | 428.60M | 432.25M | 397.75M | 389.23M | 353.33M | 338.63M | 293.33M | 209.44M | 156.64M | 8.32M |
| EBITDA | 1.24B | 1.05B | 998.31M | 982.83M | 962.66M | 883.36M | 485.37M | 696.33M | 738.62M | 718.63M | 735.67M | 854.52M | 935.83M | 778.97M | 20.11M |
| EBITDA Ratio | 32.02% | 35.59% | 41.59% | 38.49% | 32.12% | 33.17% | 22.56% | 31.46% | 30.84% | 34.37% | 35.66% | 42.91% | 46.68% | 41.96% | 11.81% |
| Operating Income | 613.48M | 559.26M | 553.90M | 543.09M | 535.87M | 412.76M | 352.88M | 308.16M | 369.91M | 373.45M | 396.32M | 570.44M | 739.87M | 606.39M | 12.15M |
| Operating Income Ratio | 15.82% | 18.80% | 22.70% | 21.26% | 18.16% | 16.46% | 16.67% | 13.97% | 15.44% | 17.86% | 19.21% | 28.67% | 37.08% | 32.47% | 7.13% |
| Total Other Income/Expenses | -54.05M | -75.42M | -62.83M | -79.10M | -59.28M | -91.81M | -378.95M | -80.42M | -87.05M | -49.04M | -18.84M | -20.56M | -23.47M | 6.20M | -1.38M |
| Income Before Tax | 559.43M | 483.84M | 491.07M | 464.00M | 476.59M | 368.17M | -26.08M | 227.73M | 282.87M | 324.41M | 377.49M | 542.59M | 716.40M | 612.59M | 10.78M |
| Income Before Tax Ratio | 14.43% | 16.27% | 20.13% | 18.16% | 16.16% | 14.68% | -1.23% | 10.33% | 11.81% | 15.51% | 18.30% | 27.27% | 35.90% | 32.80% | 6.33% |
| Income Tax Expense | 134.19M | 95.19M | 110.79M | 101.08M | 86.16M | 50.34M | 63.21M | 67.13M | 60.18M | 60.62M | 85.82M | 112.20M | 130.69M | 121.53M | 4.23M |
| Net Income | 418.87M | 356.57M | 381.63M | 366.39M | 395.17M | 323.42M | -86.70M | 158.93M | 226.52M | 265.77M | 296.86M | 430.69M | 583.45M | 483.55M | 6.30M |
| Net Income Ratio | 10.80% | 11.99% | 15.64% | 14.34% | 13.40% | 12.90% | -4.09% | 7.21% | 9.46% | 12.71% | 14.39% | 21.65% | 29.24% | 25.89% | 3.70% |
| EPS | 2.55 | 2.21 | 2.43 | 2.53 | 2.83 | 1.86 | -0.62 | 1.14 | 1.73 | 2.04 | 2.41 | 3.89 | 5.39 | 4.94 | 0.10 |
| EPS Diluted | 2.16 | 1.98 | 2.18 | 1.95 | 2.46 | 1.86 | -0.62 | 1.13 | 1.54 | 2.03 | 2.37 | 3.87 | 5.39 | 4.94 | 0.10 |
| Weighted Avg Shares Out | 164.45M | 161.38M | 157.03M | 144.96M | 139.71M | 174.34M | 139.83M | 139.74M | 130.65M | 130.07M | 123.26M | 110.95M | 108.14M | 97.85M | 60.55M |
| Weighted Avg Shares Out (Dil) | 193.57M | 191.81M | 185.67M | 201.42M | 169.88M | 174.34M | 139.87M | 140.03M | 148.20M | 131.01M | 129.75M | 111.45M | 108.15M | 97.85M | 60.55M |
Source: https://incomestatements.info
Category: Stock Reports